FDA-endorsed COVID-19 medication should be utilized warily, says UC researcher Kumar Jeetendra | January 4, 2021 While the world has its eyes on vaccines to stop the spread of coronavirus, therapeutics continue to be necessary to treat hepatitis patients. One of these treatments, remdesivir, is the first and only antiviral agent of its type the U.S. Food and Drug Administration (FDA) has approved so far for COVID-19. Research at the University …
Reimagining the future of healthcare during and beyond the pandemic Kumar Jeetendra | January 4, 2021 The COVID-19 pandemic has resulted in unprecedented disruption for the healthcare industry, pushing government, health agencies battling infectious diseases, healthcare workers, and diagnostic labs to think about alternative ways of delivering health care while adapting to the new environment. Sharing insights and learnings from the COVID-19 pandemic by Mr. Amit Chopra, Managing Director, Thermo Fisher …
Vial Sampling Kits for PFAS Analysis Kumar Jeetendra | January 4, 2021 Finneran Porvair has introduced new Convenience Kits for Per- and Polyfluoroalkyl substances (PFAS) testing. Because Per- and Polyfluoroalkyl substances don’t break down they can accumulate over time in the environment and in the human body. There is increasing evidence that exposure to PFAS can adversely affect human health. As a result, regulatory bodies** are increasingly …
High-quality SARS-CoV-2 Antigen Protein Kits Kumar Jeetendra | January 5, 2021 AMSBIO has introduced a series of kit products based upon high-quality SARS-CoV-2 antigen proteins to improve the efficiency of anti-SARS-CoV-2 drugs and vaccines development. These new kit products include SARS-CoV-2 inhibitor screening kits, antibody titer serologic assay kits, antigen detection kit and antigen pre-coated plates. SARS-CoV-2 is an enveloped positive-stranded RNA virus that consists of …
China doubles down on COVID account as WHO examination looms Kumar Jeetendra | January 5, 2021 As a team from the World Health Organization (WHO) prepares to go to China to investigate the origins of COVID-19, Beijing has stepped up efforts not only to prevent new outbreaks, but also form the story about when and where the pandemic began. China has dismissed criticism of its early handling of the coronavirus, first …
Panthera began dosing volunteers in AstraZeneca’s phase III of its long-acting antibody combination AZD7442 for the prevention of COVID-19 at its sites in Preston, North Manchester and North London Kumar Jeetendra | January 5, 2021 Panthera’s clinical trial sites in Preston, North Manchester and North London began dosing volunteers in the Phase III PROVENT trial which will evaluate AstraZeneca’s long-acting antibody combination, AZD7442, for the potential prevention of COVID-19. The double-blind, placebo-controlled trial will include adult volunteers who have no history of COVID-19 and have an increased risk of infection, …
BioNTech cautions against deferring second vaccine portion Kumar Jeetendra | January 5, 2021 German company BioNTech warned on Tuesday that there is no data backing the”safety and efficacy” of delaying the next shot of its COVID-19 vaccine beyond three weeks, as some countries push the jab to provide more people their first dose. BioNTech, which developed the vaccine with US giant Pfizer, said its clinical data showing 95 …
Biotech Team Develops ELISA Protocol for COVID-19 IgG Antibody Detection Kumar Jeetendra | January 7, 2021 Budapest, HU – 6 January 2021 – ZTA Biotech, a Budapest-based biotech startup has announced the breakthrough development of a COVID-19 antibody (IgG) test using the ELISA protocol. This new detection method represents a great step forward in determining if patients have had COVID-19 and if they might still have immunity to the disease. Early …
New strain Covid cases go up to 90 in India: Health Ministry Kumar Jeetendra | January 9, 2021 The number of people infected with the newest UK-linked version of coronavirus has gone up to 90 in India, the Union Health Ministry said on Saturday. These 90 cases comprise the 82 declared by the ministry till Friday. “The total number of cases infected with the new strain of the novel coronavirus, first reported in …
HiMedia Launches a ground-breaking 11 minute Automated Viral RNA Extraction Kumar Jeetendra | January 9, 2021 In a major breakthrough, HiGenoMB®, the Molecular Biology section of HiMedia Laboratories Pvt. Ltd. launches the quickest and the easiest 11 minute automated RNA extraction protocol. The Super 11 Pre-filled Plates for Insta NX® Mag96 (MB615MPF9611) enables processing of 96 samples in just eleven minutes! In challenging times like these, the pre-filled reagents in this …
UK supports Moderna COVID 19 vaccine for rollout against COVID-19 Kumar Jeetendra | January 9, 2021 The UK’s regulatory authority on Friday approved a third COVID-19 vaccine to be used in the nation, made by the firm Moderna. However, supplies of the new jab aren’t expected to be available until the spring in a few weeks’ time as the UK has pre-ordered 7 million doses. In trials with over 30,000, the …
Scientists disentangle the cycle that makes virus irresistible Kumar Jeetendra | January 9, 2021 Researchers have for the first time identified how viruses like the poliovirus and the common cold virus’package up’ their genetic code, allowing them to infect cells. The findings, published today (Friday, 8 January) in the journal PLOS Pathogens by a team from the Universities of Leeds and York, open up the possibility that medication or …
